Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Display:
?
Drug:  asparaginase Erwinia chrysanthemi
Find trials that include:  Any drugs shown
Results 1-5 of 5 for your search:
Start Over
Response-Based Chemotherapy in Treating Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndrome in Younger Patients with Down Syndrome
Status: Active
Phase: Phase III
Type: Biomarker/Laboratory analysis, Treatment
Age: 91 days to 3 years
Trial IDs: AAML1531, NCI-2015-00324, NCT02521493
Panobinostat, Bortezomib, and Vincristine Sulfate Liposome with Re-induction Therapy in Treating Younger Patients with Relapsed or Refractory T-cell Acute Lymphoblastic Leukemia or Lymphoma
Status: Active
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 21 and under
Trial IDs: TSALV, NCI-2015-00935, NCT02518750
Fludarabine Phosphate, Cytarabine, and Asparaginase Erwinia Chrysanthemi in Treating Patients with Relapsed or Refractory Hematologic Malignancies
Status: Not yet active
Phase: Phase II
Type: Treatment
Age: 18 to 60
Trial IDs: 2015-0807, NCI-2016-00691, NCT02718755
A Phase 2 Study of Ruxolitinib With Chemotherapy in Children With Acute Lymphoblastic Leukemia
Status: Active
Phase: Phase II
Type: Treatment
Age: 1 to 21
Trial IDs: INCB 18424-269, NCI-2016-01687, AALL1521, NCT02723994
Azacitidine or Decitabine in Epigenetic Priming in Patients with Newly Diagnosed Acute Myeloid Leukemia
Status: Active
Phase: Phase II
Type: Treatment
Age: 28 days to 22 years
Trial IDs: AML16, NCI-2017-00928, NCT03164057
Start Over